NSB Advisors’s Pfizer PFE Stock Holding History

NSB Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-7,619	Closed	-$225K	–	31
2014 Q4	$225K	Hold	7,619	–	–	0.23%	24
2014 Q3	$214K	Hold	7,619	–	–	0.18%	26
2014 Q2	$215K	Sell	7,619 -464	-6%	-$13.2K	0.15%	24
2014 Q1	$246K	Hold	8,083	–	–	0.16%	25
2013 Q4	$235K	Hold	8,083	–	–	0.14%	26
2013 Q3	$220K	Hold	8,083	–	–	0.13%	25
2013 Q2	$215K	Buy	+8,083	New	+$223K	0.12%	27

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NSB Advisors's PFE Position: Q1 2015 in Review

NSB Advisors sold out of Pfizer (PFE) in Q1 2015, closing a stake of 7,619 shares — an estimated $225K sold.

NSB Advisors first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $246K in Q1 2014. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

NSB Advisors reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
NSB Advisors sold 7,619 Pfizer shares in Q1 2015, an estimated $225K.
NSB Advisors first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
NSB Advisors's Pfizer position peaked at $246K in Q1 2014.
1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on NSB Advisors's 13F filing for Q1 2015, filed 11 May 2015.